https://www.selleckchem.com/pr....oducts/blebbistatin.
Results suggest similar regressive associations across treatment conditions Previous symptom change was the most important predictor for subsequent symptom developments. Stress at baseline and the uptake of specific treatment components only played a minor role, and stronger task/goal ratings were associated with later symptom improvements. Early symptom improvements predicted stronger midtreatment task/goal and bond ratings, whereas only stronger task/goal ratings were associated with later symptom improvements. Outcome expectatio
Like
Comment
Share
